This is your go-to spot for the latest achievements in the life sciences and high-tech startups sphere. Here, we shine a light on the trailblazers and innovators who’ve journeyed through Connect’s Springboard Program. Dive in to discover the groundbreaking milestones of the companies at the forefront of shaping our future.

Cooler Heads – has developed the first portable and FDA-approved cold cap, Amma™, to help cancer patients keep their hair as they undergo chemotherapy. The company recently announced its expansion into 22 states as well as a partnership with Sharp HealthCare in San Diego. These strategic milestones are a big step forward for Cooler Heads as their scalp-cooling device will become more available to patients and hospitals across the country. (Highlighted in November 2024)

Events.com – a leader in developing all-inclusive event management platforms with multiple capabilities, the company recently acquired California-based Remo, a virtual and immersive events platform. This strategic acquisition will expand the Events.com offerings and position the company as an all-in-one platform for both live and virtual programming. (Highlighted in Summer 2023)

HAI Solutions – a medical device company developing innovative solutions to reducing contamination of IV devices in various hospital settings, the company recently announced an international partnership with a leading global disinfection company. This joint agreement will support distribution of 3.5 million units of innovative disinfection technologies to emerging markets. (Highlighted in Fall 2024)

UGenome AI – founded in 2022, this early-stage healthtech company is developing bioinformatic solutions to accelerate the use of genomic medicine for personalized medicine treatments. The company recently announced a strategic partnership with Colorado-based Jura Health, a public benefit corporation whose mission is to drastically reduce the time needed to diagnose patients afflicted with a rare disease. Using UGenome’s pharmacogenomic profiling platform, Jura Health can quickly inform patients of their genomic profile, thereby shortening the time for patients to receive the necessary care they need.